Background/Aims: Advanced glycation end products, which are linked to both aging and hyperglycemia, cause marked functional and structural alterations in human skin. Though it is well known that the metabolism of glucose is closely associated with that of fatty acid (FA), sharing the same energy-yielding reaction pathways as glucose, its effect on the epidermis has been unclear so far. Methods: Content of ceramides, cholesterol and FA in a reconstructed epidermal model glycated by glyoxal was analyzed by high-performance thin-layer chromatography. FA species extracted from HaCaT keratinocytes was determined by gas chromatography/mass spectrometry. Regulation of FA synthesis was analyzed by real-time PCR. For physiological analysis, excised mouse skin was glycated using a vertical diffusion cell and used for the evaluation of barrier function by transepidermal water loss measurement and observation of penetration of sodium fluorescein. Results: Saturated FA content was significantly increased in glycated epidermis, and glycation upregulated mRNA expression of FA elongases 2 and 3 and FA synthase in HaCaT cells. Further, both inside-out and outside-in barriers were disrupted in glycated excised skin. Conclusion: Biological and physical change in the epidermis, especially upregulation of FA synthesis by glycation, contributed to barrier disruption, and inhibiting glycation may offer an effective treatment option for aged or glycated skin.

1.
Crisan M, Taulescu M, Crisan D, Cosgarea R, Parvu A, Cãtoi C, Drugan T: Expression of advanced glycation end-products on sun-exposed and non-exposed cutaneous sites during the ageing process in humans. PLoS One 2013;8:e75003.
2.
Schleicher ED, Wagner E, Nerlich AG: Increased accumulation of the glycoxidation product Nε-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest 1997;99:457-468.
3.
Gkogkolou, Böhm M: Advanced glycation end products: key players in skin aging? Dermatoendocrinology 2012;4:259-270.
4.
Ichihashi M, Yagi M, Nomoto K, Yonei Y: Glycation stress and photo-aging in skin. Antiaging Med 2011;8:23-29.
5.
Kawabata K, Yoshikawa H, Saruwatari K, Akazawa Y, Inoue T, Kuze T, Sayo T, Uchida N, Sugiyama Y: The presence of N(ε)-(carboxymethyl)lysine in the human epidermis. Biochim Biophys Acta 2011;1814:1246-1252.
6.
Sakai S, Kikuchi K, Satoh J, Tagami H, Inoue S: Functional properties of the stratum corneum in patients with diabetes mellitus: similarities to senile xerosis: Br J Dermatol 2005;153:319-323.
7.
Verzijl N, DeGroot J, Thorpe SR, Bank RA, Shaw JN, Lyons TJ, Bijlsma JW, Lafeber FP, Baynes JW, TeKoppele JM: Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem 2000;275:39027-39031.
8.
Yoshinaga E, Kawada A, Ono K, Fujimoto E, Wachi H, Harumiya S, Nagai R, Tajima S: Nε-(carboxymethyl)lysine modification of elastin alters its biological properties: implications for the accumulation of abnormal elastic fibers in actinic elastosis. J Invest Dermatol 2012;132:315-323.
9.
Lohwasser C, Neureiter D, Weigle B, Kirchner T, Schuppan D: The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha. J Invest Dermatol 2006;126:291-299.
10.
Leibold JS, Riehl A, Hettinger J, Durben M, Hess J, Angel P: Keratinocyte-specific deletion of the receptor RAGE modulates the kinetics of skin inflammation in vivo. J Invest Dermatol 2013;133:2400-2406.
11.
Zhu P, Ren M, Yang C, Hu YX, Ran JM, Yan L: Involvement of RAGE, MAPK and NF-κB pathways in AGE-induced MMP-9 activation in HaCaT keratinocytes. Exp Dermatol 2012;21:123-129.
12.
Listenberger LL, Ory DS, Schaffer JE: Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J Biol Chem 2001;276:14890-14895.
13.
Arner P: Insulin resistance in type 2 diabetes: role of fatty acids. Diabetes Metab Res Rev 2002;18(suppl 2):S5-S9.
14.
Uchida Y: The role of fatty acid elongation in epidermal structure and function. Dermatoendocrinology 2011;3:65-69.
15.
Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-917.
16.
Hamanaka S, Hara M, Nishio H, Otsuka F, Suzuki A, Uchida Y: Human epidermal glucosylceramides are major precursors of stratum corneum ceramides. J Invest Dermatol 2002;119:416-423.
17.
Uchida Y, Hama H, Alderson NL, Douangpanya S, Wang Y, Crumrine DA, Elias PM, Holleran WM: Fatty acid 2-hydroxylase, encoded by FA2H, accounts for differentiation-associated increase in 2-OH ceramides during keratinocyte differentiation. J Biol Chem 2007;282:13211-13219.
18.
Ohno Y, Nakamichi S, Ohkuni A, Kamiyama N, Naoe A, Tsujimura H, Yokose U, Sugiura K, Ishikawa J, Akiyama M, Kihara A: Essential role of the cytochrome P450 CYP4F22 in the production of acylceramide, the key lipid for skin permeability barrier formation. Proc Natl Acad Sci USA 2015;112:7707-7712.
19.
Fluhr JW, Kao J, Jain M, Ahn SK, Feingold KR, Elias PM: Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J Invest Dermatol 2001;117:44-51.
20.
Wang Y, Botolin D, Xu J, Christian B, Mitchell E, Jayaprakasam B, Nair MG, Peters JM, Busik JV, Olson LK, Jump DB: Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J Lipid Res 2006;47:2028-2041.
21.
Listenberger LL, Schaffer JE: Mechanisms of lipoapoptosis: implications for human heart disease. Trends Cardiovasc Med 2002;12:134-138.
22.
Strable MS, Ntambi JM: Genetic control of de novo lipogenesis: role in diet-induced obesity. Crit Rev Biochem Mol Biol 2010;45:199-214.
23.
Paumen MB, Ishida Y, Muramatsu M, Yamamoto M, Honjo T: Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis. J Biol Chem 1997;272:3324-3329.
24.
De Vries JE, Vork MM, Roemen TH, de Jong YF, Cleutjens JP, van der Vusse GJ, van Bilsen M: Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes. J Lipid Res 1997;38:1384-1394.
25.
Lee C, Yim MB, Chock PB, Yim HS, Kang SO: Oxidation-reduction properties of methylglyoxal-modified protein in relation to free radical generation. J Biol Chem 1998;273:25272-25278.
26.
Barry BW: Mode of action of penetration enhancers in human skin. J Control Release 1987;6:85-97.
27.
Yokota M, Tokudome Y: Permeation of hydrophilic molecules across glycated skin is differentially regulated by the stratum corneum and epidermis-dermis. Biol Pharm Bull 2015;38:1383-1388.
28.
Ogura Y, Kuwahara T, Akiyama M, Tajima S, Hattori K, Okamoto K, Okawa S, Yamada Y, Tagami H, Takahashi M, Hirao T: Dermal carbonyl modification is related to the yellowish color change of photo-aged Japanese facial skin. J Dermatol Sci 2011;64:45-52.
29.
Quan KK, Kusewitt DF, Hudson LG: Glyoxal leads to defective keratinocyte migration and down-regulation of Snai2 diabetes. J Dermatol Sci 2014;73:166-169.
30.
Thornalley PJ, Langborg A, Minhas HS: Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 1999;344:109-116.
31.
Kielhorn J, Pohlenz-Michel C, Schmidt S, Mangelsdorf I: Concise International Chemical Assessment Document 57. Geneva, World Health Organization, 2004.
32.
Kim EJ, Kim MK, Jin XJ, Oh JH, Kim JE, Chung JH: Skin aging and photoaging alter fatty acids composition, including 11,14, 17-eicosatrienoic acid, in the epidermis of human skin. J Korean Med Sci 2010;25:980-983.
33.
Kim EJ, Jin XJ, Kim YK, Oh IK, Kim JE, Park CH, Chung JH: UV decreases the synthesis of free fatty acids and triglycerides in the epidermis of human skin in vivo, contributing to development of skin photoaging. J Dermatol Sci 2010;57:19-26.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.